An open clinical study of high-dose (6 mg/kg tid) cefditoren pivoxil in children with bacterial pneumonia, acute otitis media and acute rhinosinusitis (Phase III)

Trial Profile

An open clinical study of high-dose (6 mg/kg tid) cefditoren pivoxil in children with bacterial pneumonia, acute otitis media and acute rhinosinusitis (Phase III)

Completed
Phase of Trial: Phase III

Latest Information Update: 20 May 2016

At a glance

  • Drugs Cefditoren pivoxil (Primary)
  • Indications Bacterial infections; Otitis media; Pneumonia; Rhinosinusitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Meiji Seika Pharma
  • Most Recent Events

    • 20 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top